Breaking the visceral fat cycle: what a 10-year follow-up of two landmark trials found

Not all fat is metabolically equal. Visceral fat — the fat packed around abdominal organs rather than under the skin — drains directly into the portal vein and drives inflammation and insulin resistance in a way subcutaneous fat does not. A 2026 Circulation paper gives the longest MRI-based look yet at what happens to visceral fat, and to the people carrying it, a full decade after a structured diet intervention.

What the follow-up did

The researchers followed participants from two earlier randomised dietary trials (CENTRAL and DIRECT-PLUS), re-scanning visceral fat by MRI at both 5 and 10 years after the original intervention ended, and linking those long-term visceral fat trajectories to cardiometabolic outcomes over the same period.

Why visceral fat specifically predicted outcomes

Participants who achieved and sustained a meaningful reduction in visceral fat during the original trial period showed better cardiometabolic health markers a decade later — independent of how much total body weight had fluctuated in between. That decoupling is the key finding: it is durable visceral fat reduction, not total scale weight, that tracked with long-term cardiometabolic health.

Practical takeaway

This reframes body-composition tracking around waist circumference and visceral fat estimates as more clinically meaningful over the long run than scale weight alone — particularly for anyone whose weight has cycled up and down over the years. A single dramatic loss that rebounds does far less for decade-scale health than a smaller, durable reduction in central adiposity that’s maintained.

This is why Misi’s body composition tracking surfaces waist and estimated visceral fat trend lines alongside scale weight, rather than treating the number on the scale as the only outcome that matters.